Phase II trial of Oxford COVID-19 vaccine candidate to begin in PGI Chandigarh
The Post Graduate Institute of Medical Education and Research (PGIMER) in Chandigarh will be beginning the Phase II trial of oxford Covid-19 vaccine candidate -- Covishield from the first week of September.
The premier institute has received approval from its internal ethical committee and is awaiting the signing of the...